Hypertension treatment results in minority patients

Area of Science:

• Cardiology
• Hypertension Management
• Health Disparities

Background:

• Limited long-term clinical trial data exists for hypertension treatment in minority populations.
• Higher prevalence of left ventricular hypertrophy and diabetes in Black patients compared to White patients is noted.
• Existing studies suggest feasibility of long-term blood pressure lowering in minority patients, with decreased morbidity and mortality.

Purpose of the Study:

• To review the current data on long-term hypertension management in minority patients.
• To assess the impact of comorbidities like left ventricular hypertrophy and diabetes on treatment choices.
• To identify effective antihypertensive medication classes for diverse populations.

Main Methods:

• Review of available long-term clinical trial data and short-term studies on hypertension treatment.
• Analysis of treatment responses in different minority groups, including Black patients.
• Evaluation of the efficacy of thiazide diuretics, calcium entry blockers, and converting enzyme inhibitors.

Main Results:

• Long-term blood pressure lowering is feasible in minority patients, leading to significant reductions in morbidity and mortality.
• Comorbidities like left ventricular hypertrophy and diabetes do not appear to significantly influence initial monotherapy choices.
• Thiazide diuretics, calcium entry blockers, and converting enzyme inhibitors are effective in lowering blood pressure, especially when combined with a diuretic.

Conclusions:

• Effective long-term blood pressure management is achievable in minority populations, improving health outcomes.
• Current evidence supports the use of specific drug classes for hypertension control across racial groups.
• Further research is needed to establish long-term treatment outcomes for Asian and Hispanic individuals with hypertension.